Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition-Reference-Cited by-同舟云学术

Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition

Published:2014-09-17 Issue:1 Volume:38 Page:170-179
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Li Ming,Zhu Lin,Xie Ao,Yuan Jieli

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10753-014-0019-7.pdf

Reference41 articles.

1. El Bialy, S.A., K.F. El Kader, and M.B. El-Ashmawy. 2011. Current progress in antifibrotics. Current Medicinal Chemistry 18: 3082–3092.

2. Friedman, S.L. 2004. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nature Clinical Practice Gastroenterology and Hepatology 1: 98–105.

3. Friedman, S.L., F.J. Roll, J. Boyles, et al. 1985. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proceedings of the National Academy of Sciences of the United States of America 82: 8681–8685.

4. Friedman, S.L., and M.B. Bansal. 2006. Reversal of hepatic fibrosis—fact or fantasy? Hepatology 43: S82–S88.

5. Chen, Y., F. Yang, H. Lu, B. Wang, et al. 2011. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54: 562–572.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review;Microorganisms;2024-08-15

2. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26

3. Characterizations of the multi-kingdom gut microbiota in Chinese patients with gouty arthritis;BMC Microbiology;2023-11-24

4. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy;Beneficial Microbes;2023-09-01

5. Harnessing the potential of probiotics in the treatment of alcoholic liver disorders;Frontiers in Pharmacology;2023-06-09